Literature DB >> 9119741

Dual infection of rabbits with human T cell lymphotropic virus types I and II.

H Machida1, N Morishita, T Ikezoe, T Sawada, Y Ohtsuki, I Miyoshi.   

Abstract

Attempts were made to generate a rabbit model of dual infection with human T lymphotropic virus (HTLV) types I and II. Four groups (A, B, C, and D) of three rabbits each were used. Group A was inoculated with the RW-1 cell line coinfected with HTLV-I and HTLV-II and group B was transfused from a dually infected rabbit. Polymerase chain reaction (PCR) using primers specific for the pol region of each virus detected both HTLV-I and HTLV-II in all group A and two group B rabbits, but HTLV-II only in the remaining group B rabbit. Groups C and D already infected with HTLV-I and HTLV-II, respectively, were inoculated with an HTLV-II- or HTLV-I-producing cell line. One group C rabbit became PCR-positive for both viruses but the other five resisted superinfection with the respective viruses. During prolonged observation, three of the six dually infected rabbits converted to single (HTLV-I or HTLV-II) infection. The in vivo dual infection was confirmed by in vitro establishment of a lymphoid cell line coinfected with HTLV-I and HTLV-II. It was also possible to establish coinfected lymphoid cell lines from HTLV-I-infected rabbits by coculture with lethally irradiated HTLV-II-producing cells and vice versa. The mechanism of viral elimination in dually infected rabbits, as well as that of protective immunity against superinfection, remains to be elucidated.

Entities:  

Mesh:

Year:  1997        PMID: 9119741      PMCID: PMC5921362          DOI: 10.1111/j.1349-7006.1997.tb00358.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  14 in total

1.  Establishment of novel lymphoid cell lines dually infected with human T cell lymphotropic viruses types I and II.

Authors:  T Kubota; N Morishita; Y Tanaka; T Sawada; T Miyagi; Y Ohtsuki; I Miyoshi
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

2.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

3.  Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.

Authors:  X Q Zhang; L Yang; D D Ho; D R Kuritzkes; I S Chen; W T Ching; Y M Chen; R T Schooley
Journal:  J Infect Dis       Date:  1992-05       Impact factor: 5.226

4.  Prophylaxis against a Melanesian variant of human T-lymphotropic virus type I (HTLV-I) in rabbits using HTLV-I immune globulin from asymptomatically infected Japanese carriers.

Authors:  Y Tanaka; K Ishii; T Sawada; Y Ohtsuki; H Hoshino; R Yanagihara; I Miyoshi
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

5.  Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.

Authors:  S K Arya; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

6.  Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits.

Authors:  R Kataoka; N Takehara; Y Iwahara; T Sawada; Y Ohtsuki; Y Dawei; H Hoshino; I Miyoshi
Journal:  Blood       Date:  1990-10-15       Impact factor: 22.113

7.  Transformation of rabbit lymphocytes with T-cell leukemia virus.

Authors:  I Miyoshi; S Yoshimoto; H Taguchi; I Kubonishi; M Fujishita; Y Ohtsuki; Y Shiraishi; T Akagi
Journal:  Gan       Date:  1983-02

8.  Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.

Authors:  G Franchini; J Tartaglia; P Markham; J Benson; J Fullen; M Wills; J Arp; G Dekaban; E Paoletti; R C Gallo
Journal:  AIDS Res Hum Retroviruses       Date:  1995-02       Impact factor: 2.205

9.  Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction.

Authors:  G D Ehrlich; J B Glaser; K LaVigne; D Quan; D Mildvan; J J Sninsky; S Kwok; L Papsidero; B J Poiesz
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

10.  Transformation of animal cells with human T-cell leukemia virus type II.

Authors:  K Miyamoto; N Tomita; K Hayashi; T Akagi
Journal:  Jpn J Cancer Res       Date:  1990-08
View more
  1 in total

Review 1.  Developing animal models for polymicrobial diseases.

Authors:  Lauren O Bakaletz
Journal:  Nat Rev Microbiol       Date:  2004-07       Impact factor: 60.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.